News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TriPoint Global Research Announces Investment Opinion on China Pharmaceuticals (CFMID.OB)


12/6/2010 11:42:24 AM

HENDERSON, Nev.--(BUSINESS WIRE)--TriPoint Global Research publishes Update Research Report by Senior Analyst Stanley Ng, on China Pharmaceuticals, Inc. (OTCBB:CFMI)

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES